Kenya Declares All-Out War on Counterfeit Drugs with Cutting-Edge Tracking System
Patients trust pharmacies to provide safe medicine, but a significant threat looms from fake, substandard, or improperly stored drugs. The Pharmacy and Poisons Board, led by CEO Ahmed Mohammed, is actively addressing these critical issues to protect public health and ensure medication integrity.When a patient walks into a pharmacy to purchase medicine, their primary intention is straightforward: to effectively treat or manage a health condition. This act is underpinned by an inherent trust in the quality and efficacy of the medication being dispensed. However, this fundamental expectation is severely jeopardized when the integrity of the medicine is compromised. A critical concern arises when the purchased medicine turns out to be fake, substandard, illegally imported, or has been subjected to improper storage conditions.
These issues pose significant threats to public health, as compromised medications can lead to ineffective treatment, adverse health outcomes, or even exacerbate existing conditions. The serious implications of such a scenario were underscored by Ahmed Mohammed, CEO of the Pharmacy and Poisons Board, during an interview conducted in Nairobi on August 17, 2026. His statements highlighted the ongoing efforts and challenges faced in ensuring that all pharmaceutical products available to the public meet stringent quality and safety standards, emphasizing the board's commitment to tackling these pervasive issues to safeguard patient well-being.